The stickier Sermo is,
the more valuable every HCP becomes.
Sermo already owns the physician graph no one else can build. A daily habit on top of that graph is the simplest lever available: time on platform compounds into richer signal, and richer signal makes the HCP audience meaningfully more valuable to every partner Sermo works with.
A daily, topic-first social layer for verified HCPs.
SermoSocial sits natively on top of Sermo. It turns the pubs, trials, congress moments and physician conversations Sermo already sees into a daily feed of AI-synthesized reels, briefs, articles, digests and podcasts, with a peer discussion attached to every piece.
- Follow topics, not people
- AI does the synthesis
- Cadence tuned to the signal
- Peer thread on every piece
Follow topics, not people,
with social mechanics.
On SermoSocial, topics are the handles: indications, drugs, biomarkers, congresses, trials. HCPs follow the topics they care about, group them into bespoke clusters, and Sermo does the rest: generates the right format at the right cadence for each topic, and puts a peer thread under every piece.
NSCLC, TROP2, tarlatamab, ESMO. HCPs follow what matters to their practice, not who happens to post about it.
Combine a biomarker, a drug and a congress into one personal feed. The graph bends to the HCP, not the other way round.
Likes, comments, references and shares on every piece. The peer conversation stays inside Sermo, where it belongs.
Sponsored content, cohort-targeted.
Because topics are handles, pharma partners can reach exactly the HCP cohort that matters, in the exact format HCPs are already reading. The placement lives natively in the feed, tuned to the moments partners care about most: launches, congresses, guideline changes.
- Cohort defined by the topics HCPs choose to follow
- Native formats, indistinguishable in quality from editorial
- Priced around the moments that move the market
A pharma partner sponsors a native brief on the latest OS readout, delivered inside the same feed those HCPs already open every morning. Same format as editorial, clearly labelled, tuned to the cohort by topic, not proxy.
A proprietary insight layer, downstream.
Aggregate, de-identified behaviour on SermoSocial becomes a signal product in its own right: what verified HCPs are engaging with, questioning, endorsing, at cohort level. Sellable to pharma, market research and Sermo's own insight products.
Which indications, drugs and biomarkers are gaining HCP attention week by week.
What specialists are engaging with, endorsing or questioning under every piece.
How attention moves around launches, congresses and guideline updates.
Read differences across specialties, geographies and career stage, always aggregate.
The prototype is running.
Take a look.
Everything in the last five slides is live end-to-end in a working prototype. Sign in and the feed plays back exactly as described.
- Followed topics across NSCLC, SCLC and brain mets
- A live daily feed of reels, briefs, articles, digests and podcasts
- Activity + references attached to every piece